CA
NZ
UK
AU
IND
US
…
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Clever Leaves Holdings is an international medical-cannabis company that cultivates, manufactures and distributes pharmaceutical-grade cannabis and extracts from facilities in Latin America and Europe. Long-term growth may be supported by low-cost Colombian cultivation, EU manufacturing capacity and expanding medical cannabis regulation, and investors may view its vertically integrated, GMP-focused platform as a route to global supply and contract opportunities.
Principal risks include regulatory and legal uncertainty across jurisdictions, competitive and pricing pressure, operational and cross-border manufacturing challenges, and limited liquidity and financing disclosure typical of OTC-listed cannabis companies.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -19.73M | -72.45M | -44.68M | -36.67M | -45.88M |
| Minority interest | - | - | 0.00M | - | 4.70M |
| Net income | -17.90M | -66.10M | -45.63M | -41.41M | -48.13M |
| Selling general administrative | 17.99M | 27.82M | 38.40M | 29.83M | 34.98M |
| Selling and marketing expenses | 2.04M | 1.90M | 3.80M | 2.58M | 3.18M |
| Gross profit | 6.56M | 4.33M | 6.81M | 7.41M | 3.10M |
| Reconciled depreciation | 3.02M | 3.67M | 3.51M | 3.59M | 1.48M |
| Ebit | -19.68M | -29.16M | -38.70M | -26.85M | -36.54M |
| Ebitda | -16.84M | -25.69M | -34.69M | -24.71M | -35.59M |
| Depreciation and amortization | 2.85M | 3.47M | 4.01M | 2.14M | 0.95M |
| Non operating income net other | - | - | - | -7.10M | - |
| Operating income | -15.59M | -29.16M | -38.70M | -26.85M | -36.54M |
| Other operating expenses | 33.01M | 46.96M | 54.07M | 38.96M | 44.37M |
| Interest expense | 0.05M | 2.70M | 6.82M | 4.46M | 2.68M |
| Tax provision | 0.30M | -6.35M | 0.95M | 0.00M | 0.00M |
| Net interest income | -0.03M | -2.70M | -6.82M | -4.46M | -2.68M |
| Non recurring | - | - | - | 1.68M | - |
| Income tax expense | 0.07M | -6.35M | 0.95M | 4.74M | 2.25M |
| Total revenue | 17.42M | 17.80M | 15.37M | 12.12M | 7.83M |
| Total operating expenses | 22.15M | 33.49M | 45.51M | 34.26M | 39.64M |
| Cost of revenue | 10.86M | 13.47M | 8.56M | 4.70M | 4.73M |
| Total other income expense net | -4.13M | -43.30M | -5.98M | -9.83M | -9.34M |
| Net income from continuing ops | -50.69M | -66.17M | -45.73M | -36.67M | -45.98M |
| Net income applicable to common shares | - | - | -45.73M | -36.11M | -39.53M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 31.24M | 52.10M | 116.16M | 165.88M | 95.72M |
| Intangible assets | 2.65M | 3.35M | 23.12M | 24.28M | 25.51M |
| Other current assets | 0.55M | 3.15M | 0.47M | 3.53M | 4.44M |
| Total liab | 7.03M | 11.69M | 43.39M | 51.57M | 45.52M |
| Total stockholder equity | 24.22M | 40.41M | 72.77M | 114.31M | 45.50M |
| Deferred long term liab | - | - | - | 5.70M | - |
| Other current liab | 2.07M | 4.35M | 5.10M | 4.87M | 2.72M |
| Common stock | - | 3.36M | - | - | - |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | -198.80M | -180.91M | -114.74M | -79.79M | -31.93M |
| Other liab | - | - | 8.56M | 7.56M | 5.70M |
| Good will | - | - | 0.00M | 18.51M | 20.19M |
| Other assets | 0.00M | - | 0.26M | 0.05M | 0.00M |
| Cash | 6.83M | 12.45M | 37.23M | 79.46M | 12.04M |
| Total current liabilities | 5.81M | 9.43M | 27.25M | 10.16M | 6.10M |
| Current deferred revenue | 0.02M | 1.07M | 0.65M | 0.87M | - |
| Net debt | -4.74M | -8.59M | -12.13M | -45.62M | 21.68M |
| Short term debt | 1.27M | 1.70M | 17.51M | - | - |
| Short long term debt | 0.50M | 0.47M | 17.51M | - | - |
| Short long term debt total | 2.09M | 3.86M | 25.09M | 33.84M | 33.73M |
| Other stockholder equity | 223.02M | 217.95M | 187.51M | 194.10M | 77.43M |
| Property plant equipment | - | - | 30.93M | 25.68M | 24.37M |
| Total current assets | 13.94M | 26.25M | 60.39M | 95.81M | 23.50M |
| Long term investments | 0.00M | 5.68M | 1.46M | 1.55M | 2.08M |
| Net tangible assets | - | - | 49.65M | 52.46M | -0.20M |
| Net receivables | 2.08M | 4.32M | 7.29M | 6.16M | 1.60M |
| Long term debt | 0.72M | 1.06M | 7.59M | 33.84M | 33.73M |
| Inventory | 4.48M | 8.40M | 15.41M | 10.19M | 5.42M |
| Accounts payable | 2.06M | 2.30M | 3.98M | 4.43M | 3.37M |
| Accumulated other comprehensive income | 0.00M | - | - | - | - |
| Retained earnings total equity | - | - | - | -69.01M | - |
| Non currrent assets other | 1.50M | 6.70M | 0.26M | 0.05M | 0.07M |
| Non current assets total | 17.30M | 25.85M | 55.77M | 70.07M | 72.22M |
| Capital lease obligations | 0.87M | 2.33M | - | - | - |
| Long term debt total | - | - | - | 33.84M | - |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 3.19M | 1.19M | -7.28M | -3.67M | -1.80M |
| Change to liabilities | - | - | -4.20M | 6.00M | 3.79M |
| Total cashflows from investing activities | 4.69M | - | -7.28M | -3.67M | -33.90M |
| Net borrowings | -0.48M | - | 1.38M | 6.54M | 34.13M |
| Total cash from financing activities | 0.66M | 3.29M | 1.83M | 91.84M | 62.83M |
| Change to operating activities | - | - | -1.37M | -0.11M | -2.79M |
| Net income | -19.80M | -66.17M | -45.73M | -36.67M | -45.98M |
| Change in cash | -5.99M | -24.81M | -41.76M | 66.26M | -8.06M |
| Begin period cash flow | 12.89M | 37.70M | 79.46M | 13.20M | 21.26M |
| End period cash flow | 6.90M | 12.89M | 37.70M | 79.46M | 13.20M |
| Total cash from operating activities | -11.51M | -29.07M | -36.23M | -21.96M | -37.05M |
| Issuance of capital stock | 1.34M | 27.69M | 0.00M | 18.02M | 28.57M |
| Depreciation | 2.85M | 3.67M | 3.51M | 3.59M | 1.48M |
| Other cashflows from investing activities | 2.86M | - | - | - | - |
| Dividends paid | - | - | - | 10.75M | - |
| Change to inventory | 2.56M | -4.45M | -8.20M | -4.77M | -1.26M |
| Change to account receivables | 1.40M | -0.28M | -0.55M | -1.15M | -0.53M |
| Sale purchase of stock | - | - | 0.00M | -6.25M | 0.00M |
| Other cashflows from financing activities | -0.20M | -1.27M | 28.37M | 95.01M | 34.88M |
| Change to netincome | - | - | 16.07M | 0.38M | 1.79M |
| Capital expenditures | 0.03M | 1.31M | 7.28M | 3.67M | 18.68M |
| Change receivables | - | - | - | -1.38M | - |
| Cash flows other operating | - | - | - | 10.83M | - |
| Cash and cash equivalents changes | - | - | - | 66.21M | - |
| Change in working capital | 0.14M | -9.00M | -14.31M | -0.04M | -0.79M |
| Stock based compensation | 0.82M | 2.34M | 11.45M | 1.65M | 1.52M |
| Other non cash items | 4.49M | 46.73M | 7.89M | 3.85M | 0.55M |
| Free cash flow | -11.54M | -30.37M | -43.51M | -25.63M | -55.73M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CLVR Clever Leaves Holdings Inc |
- -% |
0.00 | - | - | - | - | 0.21 | -0.07 |
| MKKGY Merck KGaA ADR |
-0.22 0.66% |
33.17 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
-2.76 1.62% |
167.12 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
-0.17 0.80% |
21.02 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.85 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Bodega 19-B, Parque Ind. Tibitoc P.H, Tocancipá, Colombia, 251017
561 634 7430
296
| Name | Title | Year Born |
|---|---|---|
| Mr. Andres Fajardo | Co-Founder, CEO & Director | 1978 |
| Mr. Henry R. Hague III | Chief Financial Officer | 1972 |
| Mr. Gustavo Escobar | Chief Operating Officer | NA |
| Mr. David M. Kastin Esq. | Gen. Counsel & Corp. Sec. | 1968 |
| Diana Sigüenza | Strategic Communications Director | NA |
| Mr. Amit Pandey | Exec. VP of Fin. | 1982 |
| Mr. Julian Wilches | Chief Regulatory Officer | 1979 |
| Mr. Andrew Miller | Head of Bus. Devel. | NA |
| Mr. Camilo Bohorquez | Head of Colombia | NA |
| Ms. Caroline Kliess | Managing Director of Germany | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.61%
Communication Services
-0.21%
Consumer Cyclical
-0.26%
Consumer Defensive
-0.37%
Energy
+0.23%
Financial Services
-0.43%
Financials
+0.39%
Healthcare
+0.88%
Industrials
+0.36%
Real Estate
-0.51%
Technology
+1.35%
Utilities
+0.19%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...